Datroway 100 mg powder for concentrate for solution for infusion
- Licence status
- Active substances
- Datopotamab deruxtecan
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/25/1915/001
- Licence holder
- Daiichi Sankyo Europe GmbH
Product documents
Licence information
- ATC code
- L01FX35 datopotamab deruxtecan
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription. (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 04/04/2025